Columbia Public Health is
working to address COVID-19
Discovery & Impact
We advance research and solutions to improve health for all.
As COVID-19 impacts communities of color, including elevated rates of severe illness and death, Columbia Public Health experts highlight the factors that give rise to those outcomes.
The Center for Infection and Immunity has been granted approval to launch clinical trials to determine whether blood plasma from COVID-19 survivors can be used to prevent infections in unexposed individuals, and if it can treat patients with COVID-19.
Since the novel coronavirus was first identified, Columbia Public Health has been working on multiple fronts to respond to the spread of the virus.
Hear our faculty weigh in on the public health challenges of today. This spring, we are exploring the novel coronavirus.
Pandemic Impact Fund
Help advance our School’s work to respond to COVID-19.
About Us
Entrance of the Allan Rosenfield Building at the Mailman School of Public Health
Founded
1922
as the DeLamar Institute of Public Health
Ranked
#
4
among national Public Health Schools
More than
16,000
graduates worldwide in our alumni community
After graduation
97
%
of students are employed or continuing studies
Our Community
Keep up with our inspiring students and alumni.
Ava Kamb, Advocates for Asian American Health, Columbia University Mailman School of Public Health
Ava Kamb, president of the student group Advocates for Asian American Health (AAAH), writes about racializing public health crises and the role that plays in perpetuating harmful myths.
Ogooluwa Fayemiwo, Columbia university Mailman school of public health
Ogooluwa Fayemiwo, an MPH student, writes about the unique combination of compassion and leadership that public health students possess and why science needs them more than ever.
Are you interested in a career in public health?
Apply Today